In 1922, Canadian scientists isolated insulin for the first time. Now, over 80 years later, our neighbors to the north are helping diabetics again by devising the cheapest way yet to produce insulin. This advance could significantly reduce the expense of treating the disease, which currently costs the US $132 billion dollars a year.
To create the cheap "prairie insulin," scientists at the University of Calgary genetically engineered the human gene for insulin into the common plant safflower. Once the gene activates, the flower begins producing insulin faster than traditional methods that utilize pigs, cows, yeast or bacteria.
This is the first instance of a plant producing the insulin, and it does so prolifically, to the tune of 2.2 pounds of insulin per acre of flowers. At that rate, 25 square miles of safflower could produce enough insulin for the world's entire diabetic population.
Read the full story at CTV.
Latest from Garden Center
- University of Florida study unlocks secrets of invasive short-spined thrips
- Kian-backed Eden Brothers adds Michael Hollenstein as CEO, expands senior leadership team
- IPPS announces organizational rebrand, new website and 2026 international membership drive
- Growscape appoints chief manufacturing officer, Brian Cunningham
- Experts help Florida cemetery become state’s first to earn arboretum accreditation
- Fresh Inset appoints Gordon Robertson as general manager, North America
- Society of American Florists planning fifth annual Next Gen LIVE! conference for young floral professionals
- Applications now open for American Floral Endowment graduate scholarships
